{
  "name": "Symbol Therapeutics",
  "description": "Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein, which is a modified form of the endogenous Semaphorin3A, for the treatment of Systemic Lupus Erythematosus (SLE) and other autoimmune diseases.",
  "categoryId": 12,
  "size": "xs",
  "logoFile": "logos/symbol_therapeutics-logo.webp",
  "websiteUrl": "http://symboltx.com",
  "careersUrl": null,
  "linkedinId": null,
  "linkedinNum": null,
  "crunchbaseId": "symbol-therapeutics",
  "ivcId": "A1000000400847",
  "finderId": "symbol-therapeutics",
  "xId": null,
  "facebookId": null,
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": "רמון אילן",
      "houseNumber": 2,
      "city": "נס ציונה",
      "lat": 31.9177299,
      "lon": 34.80439671200948
    }
  ],
  "isMultinational": false,
  "isActive": true
}